跳至主要内容
临床试验/NCT01170195
NCT01170195Unknown1 期

Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms

F&C Licorice Ltd1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
120
试验地点
1
主要终点
A beneficial effect of the licorice extract on postmenopausal symptoms (vasomotor symptoms, and nocturnal episodes) in symptomatic postmenopausal women

研究概览

简要总结

The purpose of the proposed study is to test the effect of Licorice Root Extract- Licogen on postmenopausal symptoms in postmenopausal women. Specifically, the study will also test the effect of the licorice extract on vaginal dryness.

详细描述

The estrogenic properties of glabridin, the major isoflavan in licorice root, were tested in view of the resemblance of its structure and lipophilicity to those of estradiol. The results indicate that glabridin is a phytoestrogen, binding to the human estrogen receptor and stimulating creatine kinase activity in rat uterus, epiphyseal cartilage, diaphyseal bone, aorta, and left ventricle of the heart. The stimulatory effects of 2.5-25 mg/animal glabridin were similar to those of 5 mg/animal estradiol. Chemical modification of glabridin showed that the position of the hydroxyl groups has a significant role in binding to the human estrogen receptor and in proliferation-inducing activity. Glabridin was found to be three to four times more active than 2*-O-methylglabridin and 4*-O-methylglabridin, and both derivatives were more active than 2*,4*- O-methylglabridin. The effect of increasing concentrations of glabridin on the growth of breast tumor cells was biphasic. Glabridin showed an estrogen receptor-dependent, growth-promoting effect at low concentrations (10 nM-10 mM) and estrogen receptor-independent antiproliferative activity at concentrations of >15 mM. This is the first study to indicate that isoflavans have estrogen-like activities. Glabridin and its derivatives exhibited varying degrees of estrogen receptor agonism in different tests and demonstrated growth-inhibitory actions on breast cancer cells.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women between the ages 45-60,
  • Who are post-menopausal (proved by a laboratory test of FSH > 30 International units),
  • Patients who report having post-menopausal symptoms, who report having, at least 5-7 hot flushes per day, as well as wakeful night episodes and nocturnal sweating (measured by Greenscale or Cooperman Index).

排除标准

  • Female patients who are outside the age boundaries of 45-60,
  • Have FSH <30
  • Patients who presently have cancer of any kind,
  • Patients that are on any other treatment for relieving post-menopausal symptoms
  • Patients who have contraindication to Licorice.

结局指标

主要结局

A beneficial effect of the licorice extract on postmenopausal symptoms (vasomotor symptoms, and nocturnal episodes) in symptomatic postmenopausal women

时间窗: 20 weeks

This outcome will be measured by: a diary in which she should report daily. The reporting would be for 3 parameters: number of hot flushes per day, wakefull night episodes and nocturnal sweating measured by Greens Climateric Scale

A beneficial effect of the licorice extract on vaginal complaints in symptomatic postmenopausal women

时间窗: 20 weeks

this objective will be measured by Pap Smear, Vaginal Ultra sound and vaginal PH

次要结局

未报告次要终点

研究者

发起方
F&C Licorice Ltd
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Effectiveness of Licorice Extract Dietary Supplement... | 临床试验